Organization | Latvian Biomedical Research and Study Centre

Latvian Biomedical Research and Study Centre Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial

2016

NCT02047994

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Academic Histology laboratory, SIA, Latvia | Latvian Biomedical Research and Study Centre

Active Ingredients

Drugs in Phase 4 Trials (5)

clarithromycin (biaxin) (1 trial)

esomeprazole (nexium) (1 trial)

metronidazole (flagyl) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

tetracycline (tetrex) (1 trial)

Drugs in Other Trials (1)

potassium iodide (thyro-block) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Gastritis (Phase 4)

Gastritis, Atrophic (Phase 4)

Stomach Neoplasms (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 2
# of Trial APIs: 6